The hucMSC-Ex reversed this trend by downregulating IL-6, TNF-α, and IL-1β, and upregulating IL-10, which shows that hucMSC-Ex has an anti-inflammatory repair effect on IBD in mice from the molecular level (Fig. 2i). Here, IL6 is linked to inflammatory bowel disease.